Scope Fluidics SA engages in the research and development in the field of healthcare. It conducts projects for bacteria and virus detection, drug resistance and blood testing. The company's projects include PCR|ONE and BacterOMIC. Scope Fluidics was founded by Piotr Garstecki, Robert Piotr Holyst and Marcin Michal Izydorzak in 2010 and is headquartered in Warsaw, Poland.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company